NOX 2.86% 7.2¢ noxopharm limited

LuPIN trial data will be presented by A/Professor Louise Emmett...

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    LuPIN trial data will be presented by A/Professor Louise Emmett at the ASCO GU Conference in San Francisco 13-15 Feb 2020, according to the NOX website

    GK said at the last AGM that the LuPIN trial was great value for money, costing just $5,000 per patient; and that data so far for LuPSMA + NOX66 was clearly superior to LuPSMA alone. I expect to see that superiority reinforced in the February presentation.

 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.